Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.

The Prostate - 1 May 2021

Sabol Rachel A, Ledet Elisa M, Jaeger Ellen, Hatton Whitley, Moses Marcus, Lankford Anjali, Zaheria Alexa, Barata Pedro, Layton Jodi L, Lewis Brian E, Sartor Oliver

Abstract excerpt

BACKGROUND: Recent literature highlights the importance of germline genetic testing in prostate cancer (PCa) patients. Surprisingly, a literature review indicates that family history (FH) records are incomplete in the major published studies from prostate cancer patients. METHODS: Prospective family history data were gathered from 496 men in a single institution with a personal history of PCa who underwent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Neoplasm Grading

Share to Prostate

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 33760238
DOI: 10.1002/pros.24120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.PMID 33760238Read ↗

Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic EvaluationSemantic proximity Read ↗

Genetic testing in prostate cancer management: Considerations informing primary care.Semantic proximity Read ↗

Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection ToolsSemantic proximity Read ↗

Identifying and Characterizing the Germinal Genetic Landscape of Men with Prostate Cancer—A Real‐Life Retrospective Multi‐Centered StudySemantic proximity Read ↗

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testingSemantic proximity Read ↗

Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.Semantic proximity Read ↗

Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsSemantic proximity Read ↗

Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.Semantic proximity Read ↗

Guidelines for genetic testing in prostate cancer: a scoping review.Semantic proximity Read ↗

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing GuidelinesSemantic proximity Read ↗

Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.Semantic proximity Read ↗

Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.